OraSure Technologies, Inc. (OSUR)
3.72
+0.19
(+5.38%)
USD |
NASDAQ |
Nov 04, 16:00
3.74
+0.02
(+0.54%)
After-Hours: 20:00
OraSure Technologies Enterprise Value : 113.31M for Nov. 4, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2026 | 113.31M |
| November 03, 2026 | 100.20M |
| November 02, 2026 | 95.03M |
| October 30, 2026 | 128.48M |
| October 29, 2026 | 138.13M |
| October 28, 2026 | 139.51M |
| October 27, 2026 | 143.65M |
| October 26, 2026 | 144.34M |
| October 23, 2026 | 141.58M |
| October 22, 2026 | 118.82M |
| October 21, 2026 | 122.96M |
| October 20, 2026 | 115.03M |
| October 19, 2026 | 110.55M |
| October 16, 2026 | 105.72M |
| October 15, 2026 | 119.51M |
| October 14, 2026 | 112.62M |
| October 13, 2026 | 119.51M |
| October 12, 2026 | 127.10M |
| October 09, 2026 | 125.72M |
| October 08, 2026 | 118.48M |
| October 07, 2026 | 114.00M |
| October 06, 2026 | 116.75M |
| October 05, 2026 | 140.20M |
| October 02, 2026 | 130.20M |
| October 01, 2026 | 124.34M |
| Date | Value |
|---|---|
| September 30, 2026 | 127.10M |
| September 29, 2026 | 120.20M |
| September 28, 2026 | 129.17M |
| September 25, 2026 | 127.79M |
| September 24, 2026 | 127.79M |
| September 23, 2026 | 131.93M |
| September 22, 2026 | 131.93M |
| September 21, 2026 | 111.24M |
| September 18, 2026 | 102.27M |
| September 17, 2026 | 97.44M |
| September 16, 2026 | 96.75M |
| September 15, 2026 | 95.37M |
| September 14, 2026 | 89.17M |
| September 11, 2026 | 80.89M |
| September 10, 2026 | 79.51M |
| September 09, 2026 | 88.48M |
| September 08, 2026 | 90.55M |
| September 04, 2026 | 96.75M |
| September 03, 2026 | 103.65M |
| September 02, 2026 | 105.72M |
| September 01, 2026 | 100.20M |
| August 31, 2026 | 104.34M |
| August 28, 2026 | 105.03M |
| August 27, 2026 | 111.24M |
| August 26, 2026 | 112.62M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 227.53B |
| AngioDynamics, Inc. | 496.46M |
| Alphatec Holdings, Inc. | 1.808B |
| AtriCure, Inc. | 3.239B |
| Baxter International, Inc. | 19.72B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 6.249M |
| Revenue (Quarterly) | 30.64M |
| Total Expenses (Quarterly) | 24.39M |
| EPS Diluted (Quarterly) | 0.0891 |
| Gross Profit Margin (Quarterly) | 38.91% |
| Profit Margin (Quarterly) | 20.40% |
| Earnings Yield | -18.53% |
| Normalized Earnings Yield | -23.68 |